Table: Stella Pharma -2022/23 parent results

Stella Pharma

09/05/2023 07:20

May 9 (Reuters)- 
          Stella Pharma Corporation 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2023    Mar 31, 2022    Mar 31, 2024      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          229 mln         100 mln         269 mln                 
              (+128.8 pct)     (-51.4 pct)     (+17.4 pct)               
  Operating   loss 806 mln    loss 741 mln      loss 1.31                
  Recurring   loss 775 mln    loss 764 mln      loss 1.32                
  Net         loss 778 mln    loss 767 mln      loss 1.33                
  EPS        loss 26.97 yen  loss 27.34 yen  loss 44.28 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T